My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 108

    1.

    Case of cerebrotendinous xanthomatosis. I: Unusual ophthalmic features.

    Morgan SJ, McKenna P, Bosanquet RC.

    Br J Ophthalmol. 1989 Dec;73(12):1011-4.PMID: 2611184 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.

    Koopman BJ, Wolthers BG, van der Molen JC, Nagel GT, Kruizinga W.

    Biochim Biophys Acta. 1987 Feb 14;917(2):238-46.PMID: 3801500 [PubMed - indexed for MEDLINE]Related articles

    3.

    Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.

    Berginer VM, Salen G, Shefer S.

    N Engl J Med. 1984 Dec 27;311(26):1649-52.PMID: 6504105 [PubMed - indexed for MEDLINE]Related articles

    4.

    A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.

    Kimura S, Beppu T, Kugai N, Koide Y, Fujita T, Iida K, Yamashita N, Yamashita K, Seyama Y.

    Jpn J Med. 1982 Jul;21(3):210-5.PMID: 7143816 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)]

    Wolf LM, Houdent C, Laudat MH, Brasseur G, Balacheff O, Uzac L.

    Nouv Presse Med. 1982 Mar 6;11(11):855-7. French. PMID: 7070978 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis.

    Lewis B, Mitchell WD, Marenah CB, Cortese C, Reynolds EH, Shakir R.

    Br Med J (Clin Res Ed). 1983 Jul 2;287(6384):21-2. No abstract available. PMID: 6407679 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Timely treatment of cerebrotendinous xanthomatosis, a hereditary disorder of cholesterol metabolism]

    Waterreus RJ, de Jager AE, Koopman BJ, Wolthers BG, Suurmeyer AJ.

    Ned Tijdschr Geneeskd. 1984 Aug 25;128(34):1604-7. Dutch. No abstract available. PMID: 6483031 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.

    Koopman BJ, Wolthers BG, van der Molen JC, Waterreus RJ.

    Clin Chim Acta. 1985 Oct 31;152(1-2):115-22.PMID: 4053393 [PubMed - indexed for MEDLINE]Related articles

    9.

    Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid.

    Salen G, Berginer V, Shore V, Horak I, Horak E, Tint GS, Shefer S.

    N Engl J Med. 1987 May 14;316(20):1233-8.PMID: 3106810 [PubMed - indexed for MEDLINE]Related articles

    10.

    [A case of cerebrotendinous xanthomatosis with convulsive seizures]

    Matsumuro K, Takahashi K, Matsumoto H, Okatsu Y, Kuriyama M.

    Rinsho Shinkeigaku. 1990 Feb;30(2):207-9. Review. Japanese. PMID: 2190743 [PubMed - indexed for MEDLINE]Related articles

    11.

    Parkinsonism in cerebrotendinous xanthomatosis.

    Fujiyama J, Kuriyama M, Yoshidome H, Suehara M, Eiraku N, Kashio N, Osame M.

    Jpn J Med. 1991 Mar-Apr;30(2):189-92.PMID: 1865593 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis.

    Berginer VM, Shany S, Alkalay D, Berginer J, Dekel S, Salen G, Tint GS, Gazit D.

    Metabolism. 1993 Jan;42(1):69-74.PMID: 8446051 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.

    Dotti MT, Salen G, Federico A.

    Dev Neurosci. 1991;13(4-5):371-6. Review.PMID: 1817044 [PubMed - indexed for MEDLINE]Related articles

    14.

    EEG in cerebrotendinous xanthomatosis (CTX).

    Berginer VM, Radwan H, Korczyn AD, Kott E, Salen G, Shefer S.

    Clin Electroencephalogr. 1982 Apr;13(2):89-96. No abstract available. PMID: 7094358 [PubMed - indexed for MEDLINE]Related articles

    15.

    Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.

    Tint GS, Ginsberg H, Salen G, Le NA, Shefer S.

    J Lipid Res. 1989 May;30(5):633-40.PMID: 2760539 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia]

    Kondo R, Wakamatsu N, Ishikawa A, Yuasa T, Miyatake T.

    Rinsho Shinkeigaku. 1991 Jun;31(6):677-9. Japanese. PMID: 1934787 [PubMed - indexed for MEDLINE]Related articles

    17.

    Xanthomatosis as a cause of unilateral proptosis.

    Mohan H, Sen DK, Chatterjee PK.

    Indian J Ophthalmol. 1971 Jun;19(2):77-9. No abstract available. PMID: 15744974 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.

    Chang WN, Kuriyama M, Chee EC.

    J Formos Med Assoc. 1994 Mar;93(3):256-9.PMID: 7920069 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cerebrotendinous xanthomatosis.

    Kearns WP, Wood WS.

    Arch Ophthalmol. 1976 Jan;94(1):148-50.PMID: 1247403 [PubMed - indexed for MEDLINE]Related articles

    20.

    Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.

    Canelas HM, Quintão EC, Scaff M, Vasconcelos KS, Brotto MW.

    Acta Neurol Scand. 1983 May;67(5):305-11.PMID: 6410671 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity